Medline Inc.: UBS raises target price to $49 from $43
MDLN•UBS raised its target price for Medline Inc. to $49 from $43.
Related News
IMAX Corporation’s Q3 net income rises to USD 113.81 million
IMAX•
Amex halt for UMCU
UMCU•
Procept Biorobotics Corporation: UBS raises target price to $21 from $20
PRCT•
Deals of the day: Mergers and acquisitions
WEN•
Eversource Energy says it has capacity to issue additional hybrid securities if needed
ES•